Evidence map›Paper›PMID 35784711›Full record

ArticleFrontiers in pharmacology2022

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.

Tamás Ágh, Maja Ortner Hadžiabdić, Kristina Garuoliene, Anne Gerd Granas, Emma Aarnio, Enrica Menditto, João Gregório, Pilar Barnestein-Fonseca, Vildan Mevsim, Przemysław Kardas and 1 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tamás ÁghSyreon Research Institute, Budapest, Hungary.
Maja Ortner HadžiabdićCentre for Applied Pharmacy, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Kristina GaruolienePharmacy Center, Institute of Biomedical Science, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Anne Gerd GranasSection for Pharmaceutics and Social Pharmacy, Department of Pharmacy, University of Oslo, Oslo, Norway.
Emma AarnioSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Enrica MendittoCIRFF, Center of Pharmacoeconomics and Drug Utilization Research, Department of Pharmacy University of Naples Federico II, Naples, Italy.
João GregórioCBIOS, Universidade Lusófona's Research Center for Biosciences & Health Technologies, Lisboa, Portugal.
Pilar Barnestein-FonsecaCUDECA Institute for Training and Research in Palliative Care, CUDECA Hospice Foundation, Málaga, Spain.
Vildan MevsimDepartment of Family Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Przemysław KardasMedication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Lodz, Poland.
European Network to Advance Best Practices and Technology on Medication Adherence (ENABLE)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

health economicshealth policyinterventionmedication adherencepersistencereimbursement

Identifiers

PMID35784711
PMCPMC9247400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.